参考文献:
1 Ramachandran A., Wan Ma RC, Snehalatha C. Diabetes in Asia. Lancet 2010; 375:408-418.
2 Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, Hu FB: Diabetes in Asia: epidemiology, risk factors, and pathophysiology. Jama 2009;301:2129-2140.
3 Williams R, Van Gaal L, Lucioni C. Assessing the impact of complications on the costs of Type II diabetes. Diabetologia 2002;45:S13-S17.
4 Vinik A.R, Maser R.E., Mitchell B.D., Freeman R. Diabetic Autonomic Neuropathy Diabetes Care 2003;26:1553-1579
5 Tesfaye S., Chaturvedi N., Eaton S.E.,et al. Vascular Risk Factors and Diabetic Neuropathy. N Engl J Med 2005;352:341-50.
6 Ducher M, Cerutti C, Gustin MP et al. Noninvasive exploration of cardiac autonomic neuropa thy. Four reliable methods for diabetes? Diabetes Care 1999;22:388–393
7 Low PA. Pitfalls in autonomic testing. In Low PA, ed. Clinical autonomic disorders: evaluation and management. Boston: Little, Brown, 1993:335-365.
8 Wu AY, Kong NC, de Leon FA, Pan CY, Tai TY, Yeung VT, Yoo SJ, Rouillon A, Weir MR: An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia 2005; 48:1674-1675.
9 Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. Jama 2001;286:421-426,
10 So WY, Kong AP, Ma RC, Ozaki R, Szeto CC, Chan NN, Ng V, Ho CS, Lam CW, Chow CC, Cockram CS, Chan JC, Tong PC: Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care 2006;29:2046-2052
11 Clarke PM, Glasziou P, Patel A, Chalmers J, Woodward M, Harrap SB, Salomon JA: Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis. PLoS Med 7:e1000236
12 Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG: Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 2006;69:2057-2063.
13 Wu AY, Kong NC, de Leon FA, Pan CY, Tai TY, Yeung VT, Yoo SJ, Rouillon A, Weir MR: An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia 2005;48:1674-1675.
14 Chan JC, Gagliardino JJ, Baik SH, Chantelot JM, Ferreira SR, Hancu N, Ilkova H, Ramachandran A, Aschner P: Multi-faceted Determinants For Achieving Glycemic Control: The International Diabetes Management Practice Study (IDMPS). Diabetes Care 2008; 32:227-233
15. Araki S, Haneda M, Sugimoto T, Isono M, Isshiki K, Kashiwagi A, Koya D: Factors Associated With Frequent Remission of Microalbuminuria in Patients With Type 2 Diabetes. Diabetes 2005;54:2983-2987
16 H. Mayaudon, P. O. Miloche, B. Bauduceau. A new simple method to assess sudomotor function: interest in type diabetes. Diabetes and metabolism (in press).
17 D. Hubert, P. Brunswick, D. Dusser, I. Fajac. Abnormal electrochemical skin conductance in cystic fibrosis. Journal of Cystic Fibrosis (in press).
18 Chizmadzhev A, Indenbom A.V., Kuzmin P. L. et al., “Electrical Properties of Skin at Moderate Voltages: Contribution of Appendageal Macropores,” Biophysical Journal 1998; vol. 74, pp. 843–856, 1998.
19 Myles Hollander \& Douglas A. Wolfe (1999). Nonparametric Statistical Methods, 2nd Edition, page 244. New York: John Wiley & Sons.
20. Report and recommendations of the San Antonio Conference on Diabetic Neuropathy. Consensus statement. Diabetes 1988;37:1000-1004 从优秀到卓越读后感
21. Ewing DJ, Martyn CN, Young RJ, Clarke BF: The value of cardiovascular autonomic function tests: 10 years’ experience in diabetes. Diabetes Care,1985, 8:491–498,
22.Hiroshi ITOH ,Seiji UEBORI, Mahito ASAI, Tagui KASHIWAYA, Keita ATOH, Isao MAKINO: Early Detection of Orthostatic Hypotension by Quantitative Sudomotor Axon Reflex Test(QSART) in Type 2 Diabetic Patients. Internal Medicine, 2003;42:560-564